Colostrinin-derived peptides (ReGen)

N/A

Report date: 2025/06/11 11:13:37

Base Information

Drug NameColostrinin-derived peptides (ReGen)
Drug Alias NameRG-01RG-09RG-018
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectantsantioxidant
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRegen Therapeutics
Inactive CompaniesN/A
Active IndicationsNerve DegenerationObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A